Ironwood Pharmaceuticals | IRWD - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Akebia Therapeutics USD 24.75M 11.64M 2026-06
Almirall EUR 303.77M 21.04M 2026-06
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Ardelyx USD 203.52M 683K 2026-03
Astellas Pharma JPY 320B 0 2026-06
AstraZeneca USD 26.01B 46M 2026-06
Charles River Laboratories USD 2.62B 43.15M 2026-06
Coherus Biosciences USD 51.08M 496K 2025-12
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Halozyme Therapeutics USD 1.94B 1.79M 2026-06
Incyte USD 28.42M 994K 2026-06
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
Lexicon Pharmaceuticals USD 49.68M 276K 2026-03
MacroGenics USD 68.71M 1.29M 2026-03
Moderna USD 597M 6M 2026-06
Myriad Genetics USD 120.7M 400K 2026-06
Pacira USD 363.12M 4.53M 2026-06
PTC Therapeutics USD 535.52M 248.58M 2026-06
Puma Biotechnology USD 10.87M 222K 2025-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Takeda JPY 4.42T 50.32B 2026-06
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12